The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitro
about
Pulmonary vascular disease related to hemodynamic stress in the pulmonary circulation.Abnormal trafficking of endogenously expressed BMPR2 mutant allelic products in patients with heritable pulmonary arterial hypertensionReconstruction and functional analysis of altered molecular pathways in human atherosclerotic arteriesS100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4Molecular and functional characterization of the BMPR2 gene in Pulmonary Arterial HypertensionHeritable forms of pulmonary arterial hypertension.Caveolae as organizers of pharmacologically relevant signal transduction molecules.Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.Bone morphogenetic protein receptor II is a novel mediator of endothelial nitric-oxide synthase activation.Combination use of sildenafil and simvastatin increases BMPR-II signal transduction in rats with monocrotaline-mediated pulmonary hypertension.Protein trafficking dysfunctions: Role in the pathogenesis of pulmonary arterial hypertension.Abnormal expression of NSF, α-SNAP and SNAP23 in pulmonary arterial hypertension in rats treated with monocrotaline.Initiation of BMP2 signaling in domains on the plasma membrane.Serum Caveolin-1 as a Novel Biomarker in Idiopathic Pulmonary Artery Hypertension.Pathogenic mechanisms of pulmonary arterial hypertension.Hereditary spastic paraplegia-causing mutations in atlastin-1 interfere with BMPRII trafficking.Monocrotaline pyrrole induces Smad nuclear accumulation and altered signaling expression in human pulmonary arterial endothelial cellsSupramolecular Nanofibers Enhance Growth Factor Signaling by Increasing Lipid Raft Mobility.Pathogenesis of pulmonary hypertension: a case for caveolin-1 and cell membrane integrity.Caveolins and cavins in the trafficking, maturation, and degradation of caveolae: implications for cell physiology.The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutationsDysfunction of Golgi tethers, SNAREs, and SNAPs in monocrotaline-induced pulmonary hypertension.Abnormal expression of vesicular transport proteins in pulmonary arterial hypertension in monocrotaline-treated rats.Caveolin-1 Expression and Hemodynamics in COPD Patients.Smad signaling in the rat model of monocrotaline pulmonary hypertension.Inflammation-induced caveolin-1 and BMPRII depletion promotes endothelial dysfunction and TGF-β-driven pulmonary vascular remodeling.Increased susceptibility to hypoxic pulmonary hypertension in Bmpr2 mutant mice is associated with endothelial dysfunction in the pulmonary vasculature
P2860
Q27687091-5220A470-E1F7-455D-99FA-0406F5138EAAQ28534831-61CC0425-51B8-4C6C-902B-124B3F3F4D4FQ33398803-A2246AF5-AE7E-4A91-BA5F-6518289B0F03Q33636296-E7D2F9A8-98C6-43D2-A4A9-1ED06C2B918AQ33689573-CB06A0DB-A042-4177-B362-DAD8E58AE290Q33915567-13865E5C-14E5-46E2-8984-2BBC2E46BC07Q34877306-B50B8295-3284-43DF-BF6F-2EA96B07A375Q34958933-EE7784FA-935E-4C15-9E59-98E1D76E86CEQ35311990-65C1556F-2636-4B5C-BAA9-DFCEF53D91D2Q35412283-C1FC5ACA-C267-4732-B053-27C286B8B80DQ35412349-E1FC8761-DD44-4982-9882-083F87321C3FQ35479468-AF6D4AAB-F8D7-44E0-9C24-5E1F376ADEF2Q35846419-3C0FB4E3-0D5F-4971-8945-1D343EFC278CQ36204005-56B53427-4F3C-467F-855C-434159D38FFDQ36447388-CF29FEBD-4E34-4D81-BCC2-8BA519C6D876Q36653382-4F39D27A-629B-4CE4-AF75-C915D5B1F871Q36943272-C21DA4C7-E696-479E-98E0-E8C23EB04D5AQ37104025-7E5632CC-F620-4642-9BAB-71307688DAACQ38155817-553961B8-3F2E-4065-8FCF-D6CB401D305BQ39103381-C97CBB8E-95AA-4027-A468-1CE5717714E4Q39152712-AA1EC549-350E-4DBF-85DE-FA54F281F649Q40163297-8D339CD6-8090-4676-9A97-143F4BF950ADQ41513099-31A6808C-03EA-4484-ACA3-F9E16A711546Q42626493-8493D8AF-CDBF-4417-8615-78D00557E3E2Q46158773-BC2F04B2-BC59-44D5-8B9E-624CAE293C5FQ47976665-4E9CC0F8-4E2E-4D4B-B605-DB89C713877EQ59173778-962E326F-8976-4D7B-AE9A-4445069D0389
P2860
The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitro
description
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im Jahr 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/01/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/01/01)
@nl
наукова стаття, опублікована в січні 2006
@uk
مقالة علمية (نشرت عام 2006)
@ar
name
The BMP type II receptor is lo ...... dothelium in vivo and in vitro
@ast
The BMP type II receptor is lo ...... dothelium in vivo and in vitro
@en
The BMP type II receptor is lo ...... dothelium in vivo and in vitro
@nl
type
label
The BMP type II receptor is lo ...... dothelium in vivo and in vitro
@ast
The BMP type II receptor is lo ...... dothelium in vivo and in vitro
@en
The BMP type II receptor is lo ...... dothelium in vivo and in vitro
@nl
prefLabel
The BMP type II receptor is lo ...... dothelium in vivo and in vitro
@ast
The BMP type II receptor is lo ...... dothelium in vivo and in vitro
@en
The BMP type II receptor is lo ...... dothelium in vivo and in vitro
@nl
P2093
P1476
The BMP type II receptor is lo ...... dothelium in vivo and in vitro
@en
P2093
D. W. Wilson
H. J. Segall
M. W. Lamé
P356
10.1016/J.VPH.2005.09.007
P577
2006-01-01T00:00:00Z